Gregory D. Davis, Executive of Sangamo Therapeutics SGMOQ, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $17.5K. The latest trade was on 05/25.

GD

GD

Gregory D. Davis

Head of Research & Technology

Company

Sangamo Therapeutics SGMOQ

First filing

24/11/26

Trades

19 trades

Buys / sales

0 / 1

12-month net buying

−$17.5K

Last trade

05/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Sangamo TherapeuticsSGMOQ	Open-market sale	04/22	04/23	69,827 sh	$0.25	$17,456.75	−37.7%